跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
魏 柏立
教授
,
大腸直腸外科
合聘教授
,
臨床醫學研究所
合聘教授
,
臨床基因體學暨蛋白質體學碩士學位學程
合聘教授
,
細胞治療與再生醫學國際博士學位學程
合聘教授
,
癌症生物學與藥物研發博士學位學程
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北醫學大學消化醫學研究中心
https://orcid.org/0000-0002-7275-2661
電子郵件
poliwei
tmu.edu
tw
h-index
5525
引文
39
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1995 …
2026
每年研究成果
概覽
指紋
網路
專案
(18)
研究成果
(221)
資料集
(9)
類似的個人檔案
(12)
指紋
查看啟用 Po-Li Wei 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Rectum Cancer
96%
Neoplasm
61%
Randomized Controlled Trial
51%
Colorectal Carcinoma
45%
Meta-Analysis
42%
Laparoscopic Surgery
41%
Appendectomy
32%
Morbid Obesity
31%
Chemoradiotherapy
31%
Gastroplasty
29%
Quality of Life
27%
Cancer Cell
25%
Minimally Invasive Procedure
24%
Body Mass Index
23%
Nicotine
23%
Diseases
23%
Systematic Review
21%
Malignant Neoplasm
21%
Radiation Therapy
21%
Cancer Surgery
20%
Comorbidity
20%
Breast Cancer
20%
Acute Appendicitis
20%
Gastric Banding
20%
Gastric Bypass
20%
Gastric Bypass Surgery
20%
Recurrent Disease
18%
Rectum Tumor
18%
Hemorrhoidectomy
18%
Nicotinic Receptor
18%
Colon Carcinoma
18%
Surgeon
17%
Chemotherapy
17%
Sphincter
17%
Stoma
16%
Analgesia
15%
Chemoradiation Therapy
15%
Incision
15%
Survival Rate
15%
Open Surgery
15%
Nissen Fundoplication
15%
Postoperative Complication
14%
Learning Curve
14%
Diabetes
14%
Biopsy Technique
14%
Laparotomy
13%
Bleeding
13%
Roux-en-Y Gastric Bypass
13%
Postoperative Pain
13%
Da Vinci Surgical System
13%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
100%
Malignant Neoplasm
79%
Colon Carcinoma
47%
Liver Cell Carcinoma
37%
Nicotinic Receptor
37%
Breast Cancer
32%
Nicotine
31%
Neoplasm
30%
Randomized Controlled Trial
24%
Chemotherapy Regimens
23%
Cetuximab
21%
Carcinogenesis
20%
Abdominal Cancer
18%
Bevacizumab
18%
Glucose Regulated Protein 94
18%
Reactive Oxygen Metabolite
18%
Fluorouracil
17%
Cancer Growth
16%
Cisplatin
16%
Catenin
15%
Postoperative Pain
14%
Fibronectin
14%
Nicotine-Derived Nitrosamine Ketone
13%
Gemcitabine
13%
Oxaliplatin
13%
Cyclooxygenase 2
12%
Paclitaxel
12%
Diseases
12%
Curcumin
12%
Polyphenol
12%
Bromelain
12%
Drug Dose
12%
Phloretin
12%
Drug Development
12%
Pancreas Cancer
10%
Placebo
10%
Survival Rate
10%
Overall Survival
9%
Recurrent Disease
9%
Tumor Growth
9%
Vasculotropin
9%
Receptor
9%
Epidermal Growth Factor Receptor
9%
Drug Resistance
9%
Treatment Group
8%
Wound Healing
8%
Combination Drug
8%
Hemorrhoid
8%
Glucose Transporter 2
8%
Cytotoxicity
8%
Biochemistry, Genetics and Molecular Biology
Glucose-Regulated Protein
91%
Cancer Cell
54%
Colon
44%
Cell Migration
41%
MicroRNA
39%
Thrombomodulin
36%
Mesenchymal-Epithelial Transition
31%
Gene Expression
25%
Tumor Progression
25%
Survivin
24%
Signal Transduction
22%
Cell Proliferation
20%
Catenin
20%
Expression Level
20%
Differentially Expressed Gene
20%
Heat Shock Protein
19%
Small Interfering RNA
16%
Protein Kinase B
15%
down Regulation
14%
Overall Survival
14%
Survival Rate
14%
Cadherin
13%
Vascular Endothelial Growth Factor
13%
Gene Mutation
12%
Aldehyde Dehydrogenase
12%
Vimentin
11%
Carcinogenesis
11%
Drug Resistance
11%
Cell Cycle
11%
Cell Growth
10%
Upregulation
10%
MTT Assay
10%
Protein Kinases
10%
Protein Expression
9%
Anticancer
9%
Next Generation Sequencing
9%
Bioinformatics
9%
Programmed Cell Death
8%
EMT
8%
Epidermal Growth Factor Receptor
8%
MMP2
8%
Gelatinase A
8%
Electrospinning
8%
Gemcitabine
8%
Cell Invasion
7%
P53
7%
Cyclooxygenase
7%
Disease Free Survival
7%
Interleukin 6
7%
Cell Death
7%
